Covid-19 prevention for high-risk individuals
A monoclonal antibody combination, was launched on Jan 6 in the country’s private hospitals for the prevention of Covid-19 in high-risk ...
Read moreA monoclonal antibody combination, was launched on Jan 6 in the country’s private hospitals for the prevention of Covid-19 in high-risk ...
Read moreThough previous investigations had centred on the live animal market, researchers wanted more evidence. An animal market in China’s Wuhan ...
Read moreThe public should move on and live with Covid-19 cautiously BY FATIHAH MANAF MALAYSIA has been transitioning into an endemic ...
Read moreON MARCH 31, the World Health Organisation (WHO) released the meeting report of “WHO Expert Meeting on Evaluation of Traditional ...
Read moreMODERNA’S Covid-19 vaccine works in babies, toddlers and preschoolers, the company announced on March 23, 2022, a development that could ...
Read moreThe public has valid questions and sound ideas on the Covid-19 situation that need to be addressed by experts BY ...
Read moreIt is worrying depression and anxiety symptoms during Covid-19 have doubled, compared with pre-pandemic figures BY DR ROZANIZAM ZAKARIA The ...
Read morePublic healthcare capacity and readiness, minimisation of transmission, proper self-management, new technologies and personal interventions are key in navigating the ...
Read moreWe should not mandate boosters to all groups irrespective of evidence as the significant issue of side effects is not ...
Read moreThe endemic phase planning in Malaysia is important for economic and social activities and opening international borders without restrictions, and ...
Read moreRevon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.
Tel: +603 3359 1166
Fax: +6 03 3358 0303
Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use